Covalon Technologies Inc. Enters Into Research Contract With Sir Mortimer B. Davis Jewish General Hospital (McGill University) for Preparation of Cells for Covalon’s Blood Vessel Growth Program

MISSISSAUGA, ONTARIO--(MARKET WIRE)--Jun 27, 2007 -- Covalon Technologies Ltd. (the “Corporation” or “Covalon”) (CDNX:COV.V - News) announced that it has entered into a one-year research contract with Dr. Jacques Galipeau, MD, FRCP©, Associate Professor of Medicine and Oncology of the Sir Mortimer B. Davis Jewish General Hospital (McGill University) for isolation of cells required for Covalon’s program in angiogenesis.